Mark H Ereth

6992233, Jan 31, 2006

May 31, 2002

10/164365

James Franklin Drake - Minneapolis MN, US
Mark Harold Ereth - Rochester MN, US
Lynn R. Skow - North Branch MN, US

MedaFor, Inc. - Minneapolis MN

A61F 13/00

602 48, 424443, 424446, 424447, 424448, 424449, 604304, 604307

A delivery system for the delivery of flowable medicinal, therapeutic or medicine materials has a strip with flowable material contained and restrained therein. A removable seal is provided, so that when the removable seal is removed, the flowable material will flow from a storage area onto a site selected for treatment. The removable seal may be provided with additional features such as absorbent coatings, or additional disinfectants coatings useful in preparing the wound surface to receive the flowable wound treatment material. A preferred composition is a system, article and method for the enhancement of clotting in wounds with extravascular blood flow, especially where the surface of the tissue has been broken.

20030171717, Sep 11, 2003

Dec 5, 2002

10/310717

Gianrico Farrugia - Rochester MN, US
Mark Ereth - Rochester MN, US
William Brooks - Rochester MN, US
Jerry Neubauer - Stewartville MN, US
Jim Rigotti - Hayward WI, US
Peter Schuller - Rochester MN, US
Raymond Menard - Hastings MN, US
Curtis Quady - Burnsville MN, US

A61M037/00

604/131000

An automated injection device for administration of one or more liquid medicaments that is particularly useful for self-administration of liquid medicaments such as those used to treat anaphylactic shock, heart attack, exposure to toxic agents, or other conditions may include a number of features designed to reduce both the size and complexity of the device. With reduced size, the device may provide greater convenience and portability. Importantly, the reduced size may encourage more users to carry the device, and thereby reduce the risks associated with the conditions mentioned above. With reduced complexity, the device can be constructed at a lower cost. Moreover, the device can be more reliable and simple to operate. In addition, the automated injection device may further include a wireless communication apparatus that may be activated to call for additional medical assistance when the automated injection device is deployed.

20080243091, Oct 2, 2008

Aug 22, 2007

11/843339

Mitchell R. Humphreys - Scottsdale AZ, US
Mark H. Ereth - Rochester MN, US
Matthew T. Gettman - Rochester MN, US

A61M 37/00

604264

A delivery system to provide end organ oxygenation and even systematic oxygenation in the face of ischemic result. The deliver system including a retrograde oxygenation and perfusion stent. The stent employing at least two and possibly more channels to allow flow of the perfusate from the device to the renal pelvis then to a back out to a collection apparatus. The stent may include various vital sign monitors, such as a renal pressure monitor, temperature monitor, and even an oxygenation monitor. The stent may include an anchoring device to allow the stent to be anchored into the renal pelvis in a temporary way during the retrograde oxygenation process.

6517517, Feb 11, 2003

Jun 8, 2000

09/589962

Gianrico Farrugia - Rochester MN
Mark H. Ereth - Rochester MN
Jerry Neubauer - Stewartville MN
Jim Rigotti - Rochester MN
Peter Schuller - Rochester MN

Mayo Foundation for Medical Education and Research - Rochester MN

A61M 3700

604131, 604138, 604204, 604212

An automated injection device for administration of one or more liquid medicaments that is particularly useful for self-administration of liquid medicaments such as those used to treat anaphylactic shock, heart attack, exposure to toxic agents, or other conditions may include a number of features designed to reduce both the size and complexity of the device. With reduced size, the device may provide greater convenience and portability. Importantly, the reduced size may encourage more users to carry the device, and thereby reduce the risks associated with the conditions mentioned above. With reduced complexity, the device can be constructed at a lower cost. Moreover, the device can be more reliable and simple to operate.

20230110223, Apr 13, 2023

Oct 13, 2022

17/965738

- Oakdale MN, US
Kelsey Pflepsen - Minneapolis MN, US
Mark Ereth - Oakdale MN, US

A61K 31/445
A61K 47/12
A61K 47/36
A61K 9/06
A61K 9/107

In general a hydrogel-lipid-microparticle drug delivery matrix that is tunable and has the ability to deliver sustained release pharmaceutical and / or active agents. The hydrogel-lipid-microparticle drug delivery matrix being echogenic.